Services
Company
Legal and Governance
Publication Library / Publications
A US survey across seven early-stage cancers assessing the humanistic burden of recurrence on patients and caregivers
Introduction
Patients diagnosed with an early-stage cancer are at risk of recurrence. Although the economic burden of a cancer recurrence is described in the literature, little is known about the humanistic burden of an early-stage cancer recurrence. Therefore, we surveyed patients and caregivers to understand the impact of a first cancer recurrence on patient and caregiver quality of life (QoL).
Methods
Patients with early-stage bladder, gastric, head and neck (HN), melanoma, non-small cell lung, renal cell, and triple-negative breast cancers (TNBC) that recurred and caregivers of such patients completed a self-administered, online survey exploring QoL impacts. QoL was evaluated using de novo questions and the following instruments: EQ-5D-5L (patients and caregivers), European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (patients only), and CareGiver Oncology Quality of Life questionnaire (caregivers only). Patient and caregiver responses and scores were stratified by type of cancer and type of recurrence (locoregional or distant/metastatic).
Results
Among patients (N = 202), QoL was found to differ significantly across tumor types at time of survey, with lower scores seen in patients with renal cell carcinoma, gastric cancer, and HN cancer and higher scores seen in patients with melanoma and TNBC. Among caregivers (N = 100), QoL did not differ across tumor types. In both patients and caregivers, decreases in QoL were observed from pre-recurrence to post-recurrence, with greater worsening in QoL seen with distant/metastatic versus locoregional recurrences. Most patients reported worrying and feeling anxious and stressed about their condition. Most caregivers reported worrying about the cared-for person’s cancer getting worse or coming back and that caring for the person was challenging post-recurrence.
Conclusion
Our findings demonstrate the importance of preventing recurrences and their negative impact on patients’ and caregivers’ QoL. Early-stage cancer treatments that prevent recurrences can provide better QoL.
Authors
R Aguiar-Ibáñez, K McQuarrie, A Martinez, H Penton, L DiGiovanni, R Raina, M Heisen, S Jayade
Journal
Oncology and therapy
Therapeutic Area
Oncology
Center of Excellence
Patient-Centered outcomes
Year
2025
Read full article